✦ LIBER ✦

Treatment of pancreatic pain with interpleural bupivacaine: an open trial

✍ Scribed by P. Ahlburg; M. Noreng; J. Mølgaard; K. Egebo

Book ID: 115103689
Publisher: John Wiley and Sons
Year: 1990
Tongue: English
Weight: 169 KB
Volume: 34
Category: Article
ISSN: 0001-5172
DOI: 10.1111/j.1399-6576.1990.tb03060.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Successful treatment of chronic pancreat

Successful treatment of chronic pancreatitis pain with interpleural analgesia

✍ Finn Reiestad; William B. Mcllvaine; Lars Kvalheim; Per Haraldstad; Bjorg Petter 📂 Article 📅 1989 🏛 Springer-Verlag 🌐 French ⚖ 277 KB

Hemodynamic Effects of Interpleural Lido

Hemodynamic Effects of Interpleural Lidocaine and Bupivacaine Combination in Anesthetized Dogs with and Without an Open Pericardium

✍ FABRICE BERNARD; SIMON T. KUDNIG; ERIC MONNET 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 117 KB

Thalidomide for the treatment of refract

Thalidomide for the treatment of refractory radiculopathic pain: An open label trial

✍ A. Chagnon 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 46 KB

Slow-release tramadol for treatment of c

Slow-release tramadol for treatment of chronic malignant pain – an open multicenter trial

✍ Frank Petzke; Lukas Radbruch; Rainer Sabatowski; Marko Karthaus; Annette Mertens 📂 Article 📅 2001 🏛 Springer-Verlag 🌐 English ⚖ 160 KB

P-7 Treatment of canine acne with doxycy

P-7 Treatment of canine acne with doxycycline: an open trial

✍ E. Bensignor; E. Guaguere 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 264 KB

Treatment of restless leg syndrome with

Treatment of restless leg syndrome with pergolide—an open clinical trial

✍ Juliane Winkelmann; Thomas C. Wetter; Karen Stiasny; Wolfgang H. Oertel; Claudia 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 331 KB

## Abstract Dopaminergic treatment with levodopa (L‐dopa) has been proven as the treatment of first choice in patients with restless leg syndrome (RLS). Augmentation of symptoms and end‐of‐dose rebound phenomena under L‐dopa/decarboxylase inhibitor treatment present major problems in some patients.